Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy

Preetesh Jain, Loretta Nastoupil, Jason Westin, Hun Ju Lee, Lucy Navsaria, Raphael E. Steiner, Sairah Ahmed, Omar Moghrabi, Onyeka Oriabure, Wendy Chen, Maria Badillo, Christopher R. Flowers, Michael L. Wang

Research output: Contribution to journalLetterpeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)e38-e42
JournalBritish Journal of Haematology
Volume192
Issue number2
DOIs
StatePublished - Jan 2021

Keywords

  • BTK inhibitor
  • Mantle cell lymphoma (MCL)
  • brexucabtagene autoleucel
  • chimeric antigen receptor therapy
  • ibrutinib
  • non-Hodgkin lymphoma
  • venetoclax

ASJC Scopus subject areas

  • Hematology

MD Anderson CCSG core facilities

  • Advanced Technology Genomics Core

Cite this